Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional study.
FORTA
Geriatric psychiatry
PRISCUS
Pharmacotherapy safety
Potentially inappropriate medications
Journal
Journal of neural transmission (Vienna, Austria : 1996)
ISSN: 1435-1463
Titre abrégé: J Neural Transm (Vienna)
Pays: Austria
ID NLM: 9702341
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
26
05
2022
accepted:
23
08
2022
pubmed:
2
9
2022
medline:
13
10
2022
entrez:
1
9
2022
Statut:
ppublish
Résumé
Adverse drug reactions (ADRs) constitute a frequent cause of hospitalization in older people. The risk of ADRs is increased by the prescription of potentially inappropriate medications for older people (PIMs). The PRISCUS list and the FORTA classification represent established tools to detect PIMs. The aim of the present study was to examine the prevalence and characteristics of PIM prescriptions on the gerontopsychiatric ward of a university hospital in Germany. To this aim, medication charts of 92 patients (mean age 75.9 ± 7.7 years; 66.3% female) were analyzed on a weekly basis until patient discharge by utilization of the PRISCUS list and the FORTA classification. Overall, 335 medication reviews comprising 2363 drug prescriptions were analyzed. 3.0% of the prescribed drugs were PIMs according to the PRISCUS list, with benzodiazepines and Z-drugs accounting for nearly half (49.3%) of all PIM prescriptions. 30.4% of the patients were prescribed at least one PRISCUS-PIM, while 43.5% of the study population took at least one FORTA class D drug. A considerable proportion of gerontopsychiatric patients were affected by PIMs; however, the overall number of PIM prescriptions in the study population was low. Further improvements in the quality of prescribing should target the use of sedating agents such as benzodiazepines and Z-drugs. Physicians should be aware of discrepancies between the PRISCUS list and the FORTA classification.
Identifiants
pubmed: 36050603
doi: 10.1007/s00702-022-02541-1
pii: 10.1007/s00702-022-02541-1
pmc: PMC9550757
doi:
Substances chimiques
Benzodiazepines
12794-10-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1367-1375Informations de copyright
© 2022. The Author(s).
Références
Eur J Hosp Pharm. 2016 Sep;23(5):306
pubmed: 31156871
J Clin Psychopharmacol. 2007 Dec;27(6):707-10
pubmed: 18004143
Drugs Aging. 1999 Jun;14(6):409-25
pubmed: 10408740
J Am Geriatr Soc. 2019 Apr;67(4):674-694
pubmed: 30693946
J Gen Intern Med. 2017 Dec;32(12):1301-1308
pubmed: 28849426
Eur J Clin Pharmacol. 2021 May;77(5):757-766
pubmed: 33205281
Int J Geriatr Psychiatry. 2013 Feb;28(2):173-81
pubmed: 22505357
Postgrad Med. 2017 Jan;129(1):140-148
pubmed: 27744763
J Alzheimers Dis. 2016 Nov 19;55(2):691-701
pubmed: 27716668
Ann Pharmacother. 2014 Jan;48(1):6-16
pubmed: 24396090
Expert Opin Drug Saf. 2008 Sep;7(5):525-38
pubmed: 18759705
Br J Clin Pharmacol. 2015 Oct;80(4):796-807
pubmed: 25619317
Drugs Aging. 2022 Mar;39(3):245-247
pubmed: 35194722
Pharmacopsychiatry. 2013 Mar;46(2):59-62
pubmed: 22915486
Eur Addict Res. 2010;16(4):179-84
pubmed: 20606442
Wien Klin Wochenschr. 2014 Oct;126(19-20):604-12
pubmed: 25216754
Z Gerontol Geriatr. 2013 Jan;46(1):35-47
pubmed: 22618706
Asian J Psychiatr. 2018 Mar;33:63-67
pubmed: 29529421
Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):719-27
pubmed: 23585247
Drugs Aging. 2016 Jan;33(1):37-44
pubmed: 26645294
BMJ Open. 2016 Mar 24;6(3):e010989
pubmed: 27013600
Curr Psychiatry Rep. 2021 Nov 29;23(12):87
pubmed: 34843030
Neurol Ther. 2020 Jun;9(1):151-157
pubmed: 32304025
J Am Med Dir Assoc. 2020 Mar;21(3):439.e9-439.e13
pubmed: 31542300
Clin Pharmacokinet. 2020 Nov;59(11):1393-1405
pubmed: 32394297
Psychogeriatrics. 2015 Mar;15(1):75-84
pubmed: 25514894
Lancet. 2021 Oct 23;398(10310):1487-1497
pubmed: 34688369
J Neural Transm (Vienna). 2021 Jan;128(1):49-60
pubmed: 33263172
BMJ Open. 2014 Dec 08;4(12):e006544
pubmed: 25488097
BMJ Open. 2021 Sep 17;11(9):e050344
pubmed: 34535481
PLoS One. 2021 Jul 22;16(7):e0255192
pubmed: 34293068
Swiss Med Wkly. 2017 Jul 27;147:w14471
pubmed: 28750419
Eur J Clin Pharmacol. 2021 Mar;77(3):331-339
pubmed: 33029652
Cochrane Database Syst Rev. 2021 Dec 17;12:CD013304
pubmed: 34918337
Eur J Clin Pharmacol. 2020 Mar;76(3):363-381
pubmed: 31838549
Psychiatr Prax. 2022 Jan;49(1):37-45
pubmed: 33773503
Int J Clin Pharm. 2019 Oct;41(5):1262-1271
pubmed: 31302885